Diabetic Foot Ulcer Clinical Trials

36 studies are recruiting for diabetic foot ulcer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

  1. Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

    The goal of this investigational study is to evaluate the safety and clinical performance of Tropocells Autologous Platelet-rich Fibrin (PRF) for wound care for both males and females, ages 18-80 years old, with Grade 1 and 2, mild to moderate, neuroischemic diabetic chronic foot ulcers in subjects…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi, Texas
    Locations
    2 in total
    Run by
    Estar Medical dba Medical Technologies, LTD
  2. Adapting Lifestyle Offloading for DFUs

    The goal of this pilot clinical trial is to develop and test a tailored occupational therapist-led lifestyle-focused intervention to aid patients in improving diabetic foot ulcer care. The main questions it aims to answer are to determine the acceptability and feasibility of taking a tailored lifes…

    Stage
    Not phased
    Ages
    21 and older
    Site
    University of Southern California, Los Angeles, California
    Run by
    University of Southern California
  3. A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

    This prospective, multi-center, randomized, controlled modified platform Trial compares Purified Native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care versus Standard of Care Alone in subjects with chronic DFUs.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Kent State University, College of Podiatric Medicine, Clevland, Ohio
    Run by
    Organogenesis
  4. A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers

    The study will evaluate the treatment effect of MDI-1228-mesylate Gel compared with standard of care alone for the complete healing rate at the end of 12 weeks in participants with diabetic foot ulcers (targeted ulcer). In addition, the proportion of subjects whose target ulcer area is reduced by 5…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site 001, Durham, North Carolina
    Run by
    Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.
  5. Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

    Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

    Stage
    Phase 4
    Ages
    21 and older
    Site
    Serena Group, Monroeville, Pennsylvania
    Run by
    Tiger Biosciences, LLC.
  6. Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers

    The purpose of this study is to evaluate the efficacy of dehydrated human amnion membrane (dhAM) and standard of care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Performance Foot and Ankle Specialists, Thousand Oaks, California
    Run by
    Axolotl Biologix
  7. Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

    This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.

    Stage
    Not phased
    Ages
    21 and older
    Site
    Cutting Edge Research, Circleville, Ohio
    Run by
    Stability Biologics
  8. Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center

    Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    MCR Health, Inc., Bradenton, Florida
    Run by
    Medaxis, LLC
  9. Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care

    A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers

    Stage
    Not phased
    Ages
    18 and older
    Site
    Detroit Foot and Ankle, Clinton Township, Michigan
    Run by
    Applied Biologics, LLC
  10. Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs

    This study will evaluate two human amnion/chorion membrane (ppLHACM) products and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).

    Stage
    Not phased
    Ages
    18 and older
    Site
    SerenaGroup - Monroeville, Monroeville, Pennsylvania
    Run by
    MiMedx Group, Inc.
  11. A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

    The goal of this clinical trial is to follow the progress of wounds in those with venous leg ulcers and diabetic foot ulcers while using an absorbent dressing called Mepilex Up. The main objective is to follow the progress of these wounds over time from initial visit to each follow-up visit. Partic…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Center for Clinical Research, Inc., Castro Valley, California
    Locations
    4 in total
    Run by
    Molnlycke Health Care AB

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.